Wednesday, December 31, 2008

Child Psychiatrist to Curtail Industry-Financed Activities

A prominent Harvard child psychiatrist will curtail activities financed by the drug industry while Massachusetts General Hospital investigates his failure for years to disclose the consulting fees he received from drug makers.

The psychiatrist, Dr. Joseph Biederman, a world-renowned and controversial researcher on childhood mental illness, has agreed to stop participating in speaking engagements and other activities paid for by pharmaceutical companies, and also to stop his work on industry-financed activities within the hospital. That includes clinical trials that are under way at the hospital, said Peggy Slasman, a spokeswoman for Massachusetts General.


No comments: